JP2003201246A - Antiinflammatory agent, and food and drink containing the same - Google Patents
Antiinflammatory agent, and food and drink containing the sameInfo
- Publication number
- JP2003201246A JP2003201246A JP2002244913A JP2002244913A JP2003201246A JP 2003201246 A JP2003201246 A JP 2003201246A JP 2002244913 A JP2002244913 A JP 2002244913A JP 2002244913 A JP2002244913 A JP 2002244913A JP 2003201246 A JP2003201246 A JP 2003201246A
- Authority
- JP
- Japan
- Prior art keywords
- cacao
- food
- leaves
- inflammatory agent
- scent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、花粉症等のアレルギー
性疾患に有効な抗炎症剤及びそれを含む飲食品に関する
ものである。更に詳しくは、薬物に比べ副作用が少なく
長期にわたって服用しても安全な抗炎症剤及びそれを含
む飲食品に関するものである。TECHNICAL FIELD The present invention relates to an anti-inflammatory agent effective for allergic diseases such as pollinosis and foods and drinks containing the same. More specifically, the present invention relates to an anti-inflammatory agent having fewer side effects than a drug and safe for long-term use, and foods and drinks containing the same.
【0002】[0002]
【従来の技術】アレルギー性鼻炎の一つである花粉症
は、日本国において20年以上前には存在がほとんど認
められなかった疾病であるが、近年罹患率が著しく増加
している疾病であり、現在、国民の30%が何らかのア
レルギー症状を持つと言われる。BACKGROUND OF THE INVENTION Pollenosis, which is one of allergic rhinitis, is a disease that was rarely found in Japan more than 20 years ago, but is a disease whose prevalence has increased remarkably in recent years. Currently, 30% of the people are said to have some allergic symptoms.
【0003】しかも近年では、典型的な「スギ花粉」に
アレルギー反応を示すのみならず、ヒノキやブタクサな
ど他の花粉に反応して発症する傾向があり、発症期間が
複数季へと延長してきている。また、この症状はハウス
ダストやダニ類に反応して、通年性に発症する例も増加
してきた。Moreover, in recent years, not only do allergic reactions to typical "cedar pollen" occur, but there is a tendency to develop it in response to other pollens such as cypress and ragweed, and the onset period has been extended to multiple seasons. There is. In addition, the number of cases in which this symptom develops perennially in response to house dust and mites has increased.
【0004】そこで、現在、花粉症の治療についての研
究が広くなされており、幾種類かの治療法が開発され治
療に供されているが、いずれも一長一短があり満足すべ
き治療法は認められていない。また、いったん罹患する
と、くしゃみ、鼻水、鼻閉、頭痛、しつこい目のかゆみ
等の不快な症状を呈し、治療薬による眠気などの副作用
のため、国民の生産性低下など経済面への悪影響すら懸
念されている。Therefore, studies on the treatment of hay fever are now widely conducted, and several kinds of treatment methods have been developed and provided for treatment. However, there are merits and demerits, and a satisfactory treatment method is recognized. Not not. In addition, once affected, unpleasant symptoms such as sneezing, runny nose, nasal congestion, headaches, and persistent itching of the eyes are exhibited, and side effects such as drowsiness caused by therapeutic agents may reduce the productivity of the population and may even adversely affect the economy. Has been done.
【0005】このような状況のもと、現在、薬品とし
て、抗アレルギー剤、ステロイド剤などが開発され使用
されている。これらの薬品は、長期投与による症状悪化
(リバウンド現象)、中枢神経に作用することによる眠
気、内分泌系への影響、などの副作用を伴い、また、抗
アレルギー効果も強いため、医師の管理下で使用するこ
とが必要である。Under these circumstances, antiallergic agents, steroid agents and the like are currently developed and used as medicines. These drugs have side effects such as symptom deterioration (rebound phenomenon) due to long-term administration, sleepiness due to action on the central nervous system, effects on the endocrine system, and strong antiallergic effects. It is necessary to use.
【0006】一方、安全で副作用をもたない抗アレルギ
ー素材として従来食品の中に、抗アレルギー作用を持つ
ものが探索され、食品用素材としての開発が試みられて
いる(特開昭61―291524号公報、特開平1―1
21217号公報、特開平7―215884号公報)。
たとえば、広く認知されているものとしては、甜茶(Ru
bussuavissimus)の茶葉から熱水抽出された甜茶エキ
ス、シソ(Perilla frutescens)の葉から熱水抽出され
た、シソ葉エキスがある。On the other hand, as an antiallergic material that is safe and has no side effects, one that has an antiallergic effect has been searched for in conventional foods, and development as a food material has been attempted (Japanese Patent Laid-Open No. 61-291524). Japanese Patent Laid-Open No. 1-1.
21217, and JP-A-7-215884).
For example, the well-known
bussuavissimus) tea leaves are extracted with hot water from perilla frutescens, and perilla frutescens leaves are extracted with hot water from perilla leaf extract.
【0007】これらの素材に対する臨床研究等の結果、
甜茶エキスは、特に鼻炎、くしゃみ、喉の痛みといった
循環器系のアレルギー発症を緩和、予防することが確認
されており、シソ葉エキスは、皮膚炎症といったアレル
ギー症状を緩和、予防することが確認されている。As a result of clinical research on these materials,
It has been confirmed that beetroot extract alleviates and prevents cardiovascular allergies such as rhinitis, sneezing, and sore throat, and perilla leaf extract has been confirmed to alleviate and prevent allergic symptoms such as skin inflammation. ing.
【0008】その上、これらの素材は、食経験が長い通
常食品を原料とするため長期間の常用摂取においても安
全であり副作用もないことから、抗アレルギー食品の機
能性成分として利用されている。Moreover, since these materials are made from ordinary foods that have a long eating experience, they are safe even after long-term ingestion and have no side effects, so they are used as functional ingredients of antiallergic foods. .
【0009】[0009]
【発明が解決しようとする課題】しかしながら、上記薬
品類の場合、多くの副作用が明らかであり、医師の管理
下において使用することが必要であり、長期にわたるア
レルギー症状の緩和、予防には不適である。また、上記
通常食品を原料とする場合は、副作用もなく抗アレルギ
ー素材としては優れたものであるが、アレルギー発症に
至る生体反応の一部を抑制するのみである。よって、結
果としてアレルギー症状の一部を緩和、予防することに
は効果が認められるが、全体症状を緩和、予防すること
は期待できない。However, in the case of the above-mentioned drugs, many side effects are obvious, and it is necessary to use them under the supervision of a doctor, which is not suitable for alleviation or prevention of allergic symptoms over a long period of time. is there. Further, when the above-mentioned ordinary food is used as a raw material, it is an excellent antiallergic material without side effects, but it only suppresses a part of the biological reaction leading to the development of allergy. Therefore, as a result, it is effective to alleviate or prevent some allergic symptoms, but it cannot be expected to alleviate or prevent all symptoms.
【0010】本発明は、このような事情に鑑み、発明者
の35年に及ぶ東洋医学の経験を基になされたものであ
って、本願発明の目的は、抗炎症効果に優れ、特にアレ
ルギー性鼻炎の全体症状に対して有効であり、且つ、薬
物でない食品を材料とするため薬品に見られるような重
篤な副作用等も無く、安全性が高い抗炎症剤及びそれを
含む飲食品を提供することにある。In view of such circumstances, the present invention is based on the inventor's 35 years of experience in oriental medicine, and the object of the present invention is to have an excellent anti-inflammatory effect, especially allergenicity. Providing highly safe anti-inflammatory agents and foods and drinks containing them, which are effective against all symptoms of rhinitis, and have no serious side effects such as those seen with drugs because they are made of non-drug foods To do.
【0011】[0011]
【課題を解決するための手段】前記の目的は、蘇葉、カ
カオ及び茴香の乾燥物又はその熱水抽出物を含有し、炎
症に対する抗炎症作用を有することを特徴とする抗炎症
剤によって達成される。さらに、上記乾燥物又はその熱
水抽出物に加え、フェヌグリークシード、ローズマリ
ー、ジュニパーベリー及び/又はセロリシードの乾燥物
又はその熱水抽出物を含有することで、炎症に対する抗
炎症作用が更に向上する。The above-mentioned object is achieved by an anti-inflammatory agent characterized by containing a dried product of soybean leaves, cacao and linseed or a hot water extract thereof, and having an anti-inflammatory effect on inflammation. To be done. Furthermore, in addition to the above-mentioned dried product or its hot water extract, by containing the dried product of fenugreek seeds, rosemary, juniper berries and / or celery seeds or its hot water extract, the anti-inflammatory action against inflammation is further improved. To do.
【0012】さらに、前記の目的は、上記抗炎症剤を含
有することを特徴とする飲食品によっても達成される。Further, the above object is also achieved by a food or drink containing the above anti-inflammatory agent.
【0013】一方、シソ科植物の抽出物の抗アレルギー
作用については、特開平9−87189号公報に、シソ
の葉、花、根などの抽出物の抗アレルギー作用が開示さ
れている。しかしながら、上記組み合わせによりアレル
ギー性鼻炎の全体症状に対して効果を奏することについ
ては、従来から知られるところでなく、今回の研究によ
って明らかにされたものである。On the other hand, regarding the antiallergic action of the extracts of Lamiaceae plants, Japanese Patent Application Laid-Open No. 9-87189 discloses the antiallergic action of extracts of perilla leaves, flowers, roots and the like. However, the fact that the above combination has an effect on all the symptoms of allergic rhinitis is not known so far, and is clarified by the present study.
【0014】[0014]
【発明の実施の形態】本発明による抗炎症剤の蘇葉、カ
カオ及び茴香の乾燥物の重量比率は、6〜2:6〜2:
4〜1であることが好ましく、更に好ましくは、3:
3:2である。更に、本発明による抗炎症剤の蘇葉、カ
カオ、茴香、フェヌグリークシード、ローズマリー、ジ
ュニパーベリー及びセロリシードの乾燥物の重量比率
は、6〜2:6〜2:4〜1:4〜1:4〜1:4〜
1:3〜0.3であることが好ましく、更に好ましく
は、3:3:2:2:2:2:1である。BEST MODE FOR CARRYING OUT THE INVENTION The weight ratio of dried leaves of soybean leaf, cacao and broth of the anti-inflammatory agent according to the present invention is 6 to 2: 6 to 2:
It is preferably 4 to 1, more preferably 3:
3: 2. Further, the dry weight ratio of the anti-inflammatory agent of the present invention such as Soyaba, cacao, scent, fenugreek seed, rosemary, juniper berry and celery seed is 6-2: 6-2: 4-1-1: 4-1. : 4 ~ 1: 4 ~
The ratio is preferably 1: 3 to 0.3, more preferably 3: 3: 2: 2: 2: 2: 1.
【0015】本発明による抗炎症剤の蘇葉、カカオ、茴
香、フェヌグリークシード、ローズマリー、ジュニパー
ベリー及びセロリシードの乾燥物は、粉砕し、乾燥粉末
としたものを用いても良い。The dried products of the anti-inflammatory agent of the present invention such as soybean leaves, cacao, scent, fenugreek seeds, rosemary, juniper berries and celery seeds may be pulverized into a dry powder.
【0016】熱水抽出を行なう際、上記乾燥物をそのま
ま若しくは粉砕したものから抽出を行なうのが良い。ま
た、抽出溶媒として用いる熱水と上記乾燥物との比率は
特に限定されないが、上記乾燥物に対して、熱水10〜
100重量倍、特に抽出操作や効率の点で15〜25重
量倍が好ましい。また、抽出温度は90〜100℃の範
囲とするのが良く、抽出時間は30〜50分の範囲とす
るのが好ましい。When the hot water extraction is carried out, it is preferable to carry out the extraction as it is or after pulverizing the dried product. Further, the ratio of the hot water used as the extraction solvent and the dried product is not particularly limited, but with respect to the dried product, hot water 10 to 10
It is preferably 100 times by weight, particularly 15 to 25 times by weight in terms of extraction operation and efficiency. The extraction temperature is preferably in the range of 90 to 100 ° C., and the extraction time is preferably in the range of 30 to 50 minutes.
【0017】本発明による抗炎症剤には、患者が飲用し
易いように、甘味としてステビアを蘇葉、カカオ及び茴
香を6〜2:6〜2:4〜1の比率で混合したもの対
し、3〜0.3の比率で加えても良く、また、蘇葉、カ
カオ、茴香、フェヌグリークシード、ローズマリー、ジ
ュニパーベリー及びセロリシードを6〜2:6〜2:4
〜1:4〜1:4〜1:4〜1:3〜0.3の比率で混
合したもの対し、3〜0.3の比率で加えても良い。The anti-inflammatory agent according to the present invention is prepared by mixing stevia as a sweetness with soybean leaf, cacao and scent in a ratio of 6 to 2: 6 to 2: 4 to 1 so that a patient can easily drink it. It may be added in a ratio of 3 to 0.3, and soy leaves, cacao, scent, fenugreek seeds, rosemary, juniper berries and celery seeds may be added in a ratio of 6 to 2: 6 to 2: 4.
˜1: 4˜1: 4˜1: 4˜1: 3˜0.3 may be added to the mixture in a ratio of 3˜0.3.
【0018】また、本発明による抗炎症剤は、熱水抽出
液をスプレードライやフリーズドライし、エキス顆粒と
して服用しても良い。The anti-inflammatory agent according to the present invention may be taken as an extract granule by spray-drying or freeze-drying a hot water extract.
【0019】本発明による抗炎症剤の投与量は、病状、
患者の年齢等によって変化し得るが、通常、1日当たり
乾燥物の重量として15〜25gが適当である。The dose of the anti-inflammatory agent according to the present invention depends on the medical condition,
Although it may vary depending on the age of the patient and the like, usually, a suitable weight of the dried product is 15 to 25 g per day.
【0020】また、抗炎症剤を含む飲食品中の有効成分
濃度については、飲食品の種類によって適宜変更するこ
とが可能であるが、通常、約1〜20wt%程度にする
とよい。なお、上記投与量については、一例であり、種
々の状況に応じて適宜変更可能である。The concentration of the active ingredient in the food or drink containing the anti-inflammatory agent can be appropriately changed depending on the kind of the food or drink, but it is usually about 1 to 20 wt%. It should be noted that the above-mentioned dose is an example, and can be appropriately changed according to various situations.
【0021】本発明の飲食品は、スープ類、飲料(ジュ
ース、酒、ミネラルウオーター、コーヒー、茶等)、菓
子類(ガム、キャンディー、チョコレート、スナック、
ゼリー等)、麺類(そば、うどん、ラーメン等)をはじ
めとする一般食品および、健康食品、栄養補助食品(栄
養ドリンク等)に配合することができる。これによっ
て、抵抗なく抗アレルギー物質を摂取することが可能に
なり、アレルギーの予防に役立つ。また、本発明による
飲食品の長期使用によってアレルギー体質の改善にも優
れた効果を得ることができる。The food and drink of the present invention includes soups, beverages (juice, liquor, mineral water, coffee, tea, etc.), confectionery (gum, candy, chocolate, snacks,
Jelly, etc.), noodles (soba, udon, ramen, etc.) and other general foods, health foods, nutritional supplements (nutritive drinks, etc.) can be added. This makes it possible to take antiallergic substances without resistance, which helps prevent allergies. In addition, a long-term use of the food or drink according to the present invention can provide an excellent effect on improving allergic constitution.
【0022】[0022]
【実施例】次に、実施例に基づいて本発明を具体的に説
明する。EXAMPLES Next, the present invention will be specifically described based on Examples.
【0023】[実施例1]抗炎症剤の調製
表1に示す組成でそれぞれの乾燥粉末を混合し抗炎症剤
を調製し、実施例1とした。[Example 1] Preparation of anti-inflammatory agent An anti-inflammatory agent was prepared by mixing each dry powder with the composition shown in Table 1 to give Example 1.
【0024】[比較例1]表1に示す組成でそれぞれの
乾燥粉末を混合し、比較例1とした。Comparative Example 1 Dry powders having the composition shown in Table 1 were mixed to give Comparative Example 1.
【0025】[比較例2]表1に示す組成でそれぞれの
乾燥粉末を混合し抗炎症剤を調製し、比較例2とした。Comparative Example 2 An anti-inflammatory agent was prepared by mixing each dry powder with the composition shown in Table 1 to prepare Comparative Example 2.
【0026】[実施例3]表1に示す組成でそれぞれの
乾燥粉末を混合し抗炎症剤を調製し、実施例3とした。Example 3 The dry powders having the composition shown in Table 1 were mixed to prepare an anti-inflammatory agent, which was set as Example 3.
【0027】[0027]
【表1】 [Table 1]
【0028】[試験例1]臨床試験は、以下のとおり行
なった。2月中旬〜5月中旬にかけて鼻汁、くしゃみ、
鼻閉など特有の症状を経験しているスギ花粉症患者及び
通年性のアレルギー患者42例のうち31例に本発明の
抗炎症剤である実施例1を、5例に本発明の抗炎症剤で
ある実施例3を一日2回に分けて、表1の量を100℃
の熱水で35分間抽出し服用してもらい、残りの6例の
うち3例に比較例1を一日2回に分けて、同様に服用し
てもらい、残りの3例に比較例2を一日2回に分けて、
同様に服用してもらった。服用期間4週間後に表2の基
準に従い判定を行なった。[Test Example 1] A clinical test was carried out as follows. From mid-February to mid-May, runny nose, sneeze,
Of 42 patients with cedar pollinosis and perennial allergy who are experiencing peculiar symptoms such as nasal congestion, 31 of Example 1 is the anti-inflammatory agent of the present invention, and 5 are anti-inflammatory agents of the present invention. Example 3 is divided into 2 times a day, and the amount in Table 1 is 100 ° C.
Of hot water for 35 minutes to extract, take 3 of the 6 remaining cases, take Comparative Example 1 twice a day, take the same, and give the remaining 3 cases of Comparative Example 2. Divide into twice a day,
I took it as well. The determination was made according to the criteria in Table 2 after the 4-week administration period.
【0029】[0029]
【表2】 [Table 2]
【0030】臨床試験の結果を表3に示す。The results of the clinical tests are shown in Table 3.
【0031】[0031]
【表3】 [Table 3]
【0032】上記の結果から、特に実施例1は、炎症に
対する効果が認められ、実施例3も、比較例より高い効
果が認められた。また、治療期間中、副作用と思われる
ような症状は全く認められなかった。これに対し、比較
例品はいずれも炎症に対する効果が低かった。From the above results, the effect on inflammation was recognized particularly in Example 1, and the effect in Example 3 was higher than that in Comparative Example. During the treatment period, no symptom that was considered to be a side effect was observed. On the other hand, the comparative examples had low effects on inflammation.
【0033】すなわち、蘇葉及びローズマリーからなる
比較例1や、茴香及びカカオからなる比較例2では、そ
の抗炎症効果がほとんど認められず、あるいは部分的で
あるのに対し、本発明により得られた抗炎症剤について
のみ、アレルギー性鼻炎の全体症状に対して効果を奏す
ることが明らかとなった。That is, in Comparative Example 1 consisting of soy leaves and rosemary and Comparative Example 2 consisting of scent and cacao, the anti-inflammatory effect was hardly recognized or partial, whereas in the present invention, it was obtained. It was clarified that the obtained anti-inflammatory agent was effective against all the symptoms of allergic rhinitis.
【0034】なお、実施例1については、処方開始後3
日目より、症状の改善が認められ、1週間後から症状軽
減が自覚され始め、2週間後には有効性が明確となっ
た。Regarding Example 1, 3 after the start of prescription.
From day one, improvement in symptoms was observed, and one week later, consciousness of symptom reduction began to become apparent, and two weeks later, the efficacy became clear.
【0035】次に、本発明の抗炎症剤を含有する飲食品
の例を示す。Next, examples of foods and drinks containing the anti-inflammatory agent of the present invention will be shown.
【0036】[実施例2]スープ
実施例1で得られた抗炎症剤を使用して、以下の処方に
従って常法にてスープを調製した。[Example 2] Soup Using the anti-inflammatory agent obtained in Example 1, a soup was prepared by a conventional method according to the following formulation.
【0037】 抗炎症剤 20wt% 緑豆 30wt% ステビア 1.5wt%、 食塩 1wt%、 水 47.5wt%[0037] Anti-inflammatory agent 20wt% Mung bean 30wt% Stevia 1.5wt%, Salt 1wt%, Water 47.5wt%
【0038】上記実施例の抗炎症剤を含有する飲食品に
より、日常の生活の中で容易に摂取することが可能とな
り、アレルギー性疾患を効果的に予防し、体質の改善を
容易に行うことが可能である。The foods and drinks containing the anti-inflammatory agent of the above-mentioned examples can be easily ingested in daily life, effectively prevent allergic diseases, and easily improve the constitution. Is possible.
【0039】[0039]
【発明の効果】本発明の抗炎症剤及びそれを含む飲食品
は、花粉症等のアレルギー性鼻炎等に対し優れた抗炎症
作用を有するものである。しかも食品素材を原料として
いるので、薬品に見られる重篤な副作用も無く、安全性
が高い。また、本発明の飲食品によって、日常の生活の
中でアレルギーを予防し、体質の改善を容易に行うこと
が可能である。INDUSTRIAL APPLICABILITY The anti-inflammatory agent of the present invention and foods and drinks containing the same have an excellent anti-inflammatory effect against allergic rhinitis such as pollinosis. Moreover, since it uses food materials as its raw materials, it has a high level of safety without the serious side effects of chemicals. Further, the food and drink of the present invention can prevent allergies in daily life and easily improve the constitution.
フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A23L 1/30 A23L 1/30 B A61P 11/02 A61P 11/02 27/14 27/14 27/16 27/16 29/00 29/00 37/08 37/08 Fターム(参考) 4B018 MD61 ME07 MF01 4C088 AB03 AB12 AB38 AB40 AB59 AC01 BA09 CA05 CA11 MA07 MA08 MA41 MA44 MA52 ZA33 ZA34 ZB11 ZB13 Front page continued (51) Int.Cl. 7 Identification code FI theme code (reference) A23L 1/30 A23L 1/30 B A61P 11/02 A61P 11/02 27/14 27/14 27/16 27/16 29 / 00 29/00 37/08 37/08 F term (reference) 4B018 MD61 ME07 MF01 4C088 AB03 AB12 AB38 AB40 AB59 AC01 BA09 CA05 CA11 MA07 MA08 MA41 MA44 MA52 ZA33 ZA34 ZB11 ZB13
Claims (12)
熱水抽出エキスを含有し、炎症に対する抗炎症作用を有
することを特徴とする抗炎症剤。1. An anti-inflammatory agent, which comprises a dried product of soybean leaves, cacao and cocoon or a hot water extract thereof and has an anti-inflammatory action against inflammation.
率が、6〜2:6〜2:4〜1である請求項1記載の抗
炎症剤。2. The anti-inflammatory agent according to claim 1, wherein the weight ratio of the dried product of soybean leaves, cacao and scent is 6 to 2: 6 to 2: 4 to 1.
率が、3:3:2である請求項1記載の抗炎症剤。3. The anti-inflammatory agent according to claim 1, wherein the weight ratio of the dried product of soybean leaf, cacao and scent is 3: 3: 2.
ード、ローズマリー、ジュニパーベリー及びセロリシー
ドの乾燥物又はその熱水抽出エキスを含有し、炎症に対
する抗炎症作用を有することを特徴とする抗炎症剤。4. An anti-inflammatory which comprises dried leaves of soy leaves, cacao, scent, fenugreek seeds, rosemary, juniper berries and celery seeds or a hot water extract thereof, and which has an anti-inflammatory effect on inflammation. Agent.
ード、ローズマリー、ジュニパーベリー及びセロリシー
ドの乾燥物の重量比率が、6〜2:6〜2:4〜1:4
〜1:4〜1:4〜1:3〜0.3である請求項4記載
の抗炎症剤。5. A dry product of soy leaves, cacao, scent, fenugreek seeds, rosemary, juniper berries and celery seeds in a weight ratio of 6 to 2: 6 to 2: 4 to 1: 4.
The anti-inflammatory agent according to claim 4, wherein the anti-inflammatory agent is from about 1: 4 to 1: 4 to 1: 3 to 0.3.
ード、ローズマリー、ジュニパーベリー及びセロリシー
ドの乾燥物の重量比率が、3:3:2:2:2:2:1
である請求項4記載の抗炎症剤。6. The weight ratio of dried leaves of soy leaves, cacao, scent, fenugreek seeds, rosemary, juniper berries and celery seeds is 3: 3: 2: 2: 2: 2: 1.
The anti-inflammatory agent according to claim 4, which is
カカオ及び茴香の乾燥物又はその熱水抽出エキスを含有
することを特徴とする飲食品。7. The leaves of claim 1 as an anti-inflammatory agent,
A food or drink characterized by containing a dried product of cacao or cocoa or a hot water extract thereof.
率が、6〜2:6〜2:4〜1である請求項7記載の飲
食品。8. The food or drink according to claim 7, wherein the weight ratio of dried products of soybean leaves, cacao and scent is 6 to 2: 6 to 2: 4 to 1.
率が、3:3:2である請求項7記載の飲食品9. The food and drink according to claim 7, wherein the weight ratio of the dried products of soy leaf, cacao and scent is 3: 3: 2.
葉、カカオ、茴香、フェヌグリークシード、ローズマリ
ー、ジュニパーベリー及びセロリシードの乾燥物又はそ
の熱水抽出エキスを含有することを特徴とする飲食品。10. An anti-inflammatory agent, which comprises the dried product of soybean leaf, cacao, cocoon, fenugreek seed, rosemary, juniper berry and celery seed according to claim 4, or a hot water extract thereof. Food and drink.
シード、ローズマリー、ジュニパーベリー及びセロリシ
ードの乾燥物の重量比率が、6〜2:6〜2:4〜1:
4〜1:4〜1:4〜1:3〜0.3である請求項10
記載の飲食品。11. The dry product of soy leaf, cacao, scent, fenugreek seed, rosemary, juniper berry and celery seed has a weight ratio of 6 to 2: 6 to 2: 4 to 1: 1.
It is 4 to 1: 4 to 1: 4 to 1: 3 to 0.3.
The listed food and drink.
シード、ローズマリー、ジュニパーベリー及びセロリシ
ードの乾燥物の重量比率が、3:3:2:2:2:2:
1である請求項10記載の飲食品。12. The weight ratio of dried leaves of soy leaf, cacao, scent, fenugreek seed, rosemary, juniper berry and celery seed is 3: 3: 2: 2: 2: 2 :.
The food or drink according to claim 10, which is 1.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002244913A JP2003201246A (en) | 2001-10-26 | 2002-08-26 | Antiinflammatory agent, and food and drink containing the same |
CA 2409084 CA2409084A1 (en) | 2001-10-26 | 2002-10-21 | Anti-inflammatory agent and foods and drinks containing the same |
US10/279,971 US6884442B2 (en) | 2001-10-26 | 2002-10-25 | Anti-inflammatory agent and foods and drinks containing the same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001329049 | 2001-10-26 | ||
JP2001-329049 | 2001-10-26 | ||
JP2002244913A JP2003201246A (en) | 2001-10-26 | 2002-08-26 | Antiinflammatory agent, and food and drink containing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003201246A true JP2003201246A (en) | 2003-07-18 |
Family
ID=26624130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002244913A Pending JP2003201246A (en) | 2001-10-26 | 2002-08-26 | Antiinflammatory agent, and food and drink containing the same |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2003201246A (en) |
CA (1) | CA2409084A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007007958A1 (en) * | 2005-07-08 | 2007-01-18 | Yuhan Corporation | Herbal pharmaceutical composition for regenerative agent of cartilaginous tissue and treatment of osteoarthritis |
JP2008195703A (en) * | 2007-01-20 | 2008-08-28 | Michishi Tani | Bioactive therapeutic substance |
TWI399221B (en) * | 2004-12-17 | 2013-06-21 | Colgate Palmolive Co | Oral compositions containing extracts of rosmarinus and related methods |
-
2002
- 2002-08-26 JP JP2002244913A patent/JP2003201246A/en active Pending
- 2002-10-21 CA CA 2409084 patent/CA2409084A1/en not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI399221B (en) * | 2004-12-17 | 2013-06-21 | Colgate Palmolive Co | Oral compositions containing extracts of rosmarinus and related methods |
WO2007007958A1 (en) * | 2005-07-08 | 2007-01-18 | Yuhan Corporation | Herbal pharmaceutical composition for regenerative agent of cartilaginous tissue and treatment of osteoarthritis |
JP2008195703A (en) * | 2007-01-20 | 2008-08-28 | Michishi Tani | Bioactive therapeutic substance |
Also Published As
Publication number | Publication date |
---|---|
CA2409084A1 (en) | 2003-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8227013B2 (en) | Dietary nutritional supplements for healthcare | |
WO2018058851A1 (en) | Siraitia grosvenorii-prebiotics-chrysanthemum instant tea beverage and preparation method therefor | |
CN102872306B (en) | Compound selenium Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
CN101653179B (en) | Health protection tea | |
WO2020073922A1 (en) | Health product composition for supplementing deficiency, preparation method therefor and application thereof | |
CN101829209B (en) | Preparation method of fruit-flavored sweet tea polyphenols | |
JP2003192605A (en) | Lipase inhibitant | |
TW200841829A (en) | Instant tea | |
JP2007135493A (en) | Health food | |
KR20050037444A (en) | Composition of herb tea powder for anti-obeseness and liquid thereof | |
CN107173660A (en) | A kind of health solid beverage for nursing one's health damp-heat constitution and preparation method thereof | |
JP3489095B2 (en) | Health foods and beverages | |
KR102092787B1 (en) | A pill for functional food comprising Protaetia brevitarsis seulensis and manufacturing method therof | |
JP4620783B2 (en) | Functional food composition having therapeutic effect on allergy, natural tea using the same, and method for producing the same | |
RU2673042C2 (en) | Health-improvement drink powder | |
JP2003201246A (en) | Antiinflammatory agent, and food and drink containing the same | |
JP2008007473A (en) | Cassia obtusifolia l. or cassia tora l. seed extract | |
JP2004352626A (en) | Anticholesterol agent containing plant-derived component | |
CN107683923A (en) | One kind relaxes bowel plant tea bag and preparation method thereof | |
RU2267280C2 (en) | Soft drink concentrate (variants) | |
JP2003169631A (en) | Anti-allergic drink or food | |
JP2004323439A (en) | Composition for ameliorating blood viscosity | |
JP2013035771A (en) | Aquilaria leaf composition and production method thereof, and method for producing aquilaria leaf extract | |
Khater | Herbal and Horticultural Remedies:: Gardening for the Elderly and Physically and Mentally Disabled | |
CN105941716A (en) | Greasiness relieving and digestion promoting teabag and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20051019 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20051019 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070817 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071016 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20071107 |